ImpediMed Limited at it's general meeting approved removal of Donald Williams as a director of the Company, removal of Amit Patel as a director of the Company, removal of David Anderson as a director of the Company, removal of Daniel Sharp as a director of the Company with effect from September 28, 2023, appointment of McGregor Grant as a director of the Company with effect from September 28, 2023, appointment of Christine Emmanuel-Donnelly as a director of the Company, appointment of Andrew Grant as a director of the Company and appointment of Janelle Delaney as a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.084 AUD | +5.00% | +7.69% | -42.07% |
04-30 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
04-30 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.07% | 107M | |
+12.85% | 227B | |
+13.88% | 192B | |
+18.39% | 136B | |
+28.78% | 108B | |
+1.67% | 64.07B | |
+18.24% | 52.1B | |
+7.04% | 51.87B | |
+10.83% | 44.33B | |
+5.94% | 36.75B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- Impedimed Limited Announces Board Changes